Art Therapy in Progressive Supranuclear Palsy

NCT07820878 | Completed

• 1 other identifier: H-54410
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 2

Brief Summary

Our aim is to study the effect of art therapy for people with PSP, with a focus on alleviating the symptoms associated with PSP, enhancing the overall quality of life for patients, and reducing caregiver stress. Overall, through our collaborative efforts on this study, investigators hope to unlock the benefits of art therapy for this vulnerable patient population, ultimately improving their overall well-being and enhancing their quality of life.

Conditions

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS); Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R); Progressive Supranuclear Palsy; Progressive Supranuclear Palsy(PSP); Progressive Supranuclear Palsy (PSP)

Keywords

Art Therapy; PSP

Outcome Measures

Primary Outcomes (1)

• PSP-QoL (Progressive Supranuclear Palsy Qualify of Life Scale)

  Self-reported quality of life rating scale comprising of 28 items in six categories: daily activities (by history), behavior, bulbar, ocular motor, limb motor and gait/midline. Scores range from 0 to 100, each item graded 0-2 (six items) or 0-4 (22 items). The lower the total score the better the quality of life.

  8-10 weeks

Secondary Outcomes (3)

• PHQ-9 (Patient Health Questionnaire-9)

  8-10 weeks

• NPI (Neuropsychiatric Inventory)

  8-10 weeks

• Zarit Caregiver Burden Scale

  8-10 weeks

Study Arms (1)

Art Therapy

OTHER

psp patients enrolled into study

Other: Art Thrapy

Interventions

Art Thrapy OTHER

Art therapy at Art Therapy Studio, a well-established recommended art therapy leader since 1967 with extensive experience in virtual therapy for patients with medical needs. Cheryl Pete, MA ATR-BC, a board-certified art therapist and the Clinical Director will complete the art therapy sessions. The art therapy will be a 1-hour sessions, once a week for a total of 8 weeks (or 8 sessions). Cheryl Pete's role will solely involve providing a service. Chery will complete the Art Therapy according to her standard practices. Cheryl's Art Therapy will not be altered in any way as a part of this research study. Cheryl will not collect any research data. As research participants are referred to Cheryl for the Art Therapy, the research participant's name and contact information will be shared.

Art Therapy

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of progressive supranuclear palsy
• Have the cognitive ability to provide informed consent

You may not qualify if:

• Primary neurological diagnosis other than progressive supranuclear palsy
• Cognition too impaired to provide informed consent

Sponsors & Collaborators

• Baylor College of Medicine: lead

Study Sites (2)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Supranuclear Palsy, Progressive

Condition Hierarchy (Ancestors)

Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Ophthalmoplegia; Ocular Motility Disorders; Cranial Nerve Diseases; Tauopathies; Neurodegenerative Diseases; Paralysis; Neurologic Manifestations; Eye Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Chi-Ying Roy Lin, MD, MPH

  Baylor College of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor of Neurology - Administration

Study Record Dates

• First Submitted: September 10, 2026
• First Posted: September 15, 2026
• Study Start: January 14, 2025
• Primary Completion: December 31, 2025
• Study Completion: December 31, 2025
• Last Updated: September 16, 2026

Record last verified: 2026-09

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
• Time Frame: Within 1 week of enrolling our first participant IPD will be shared. No expiration of this data.
• Access Criteria: Vanderbilt University Medical Center, the only collaborator on this project, will have access.

Locations

US (2)